000 | 01883 a2200541 4500 | ||
---|---|---|---|
005 | 20250515140750.0 | ||
264 | 0 | _c20090729 | |
008 | 200907s 0 0 eng d | ||
022 | _a1432-5233 | ||
024 | 7 |
_a10.1007/s00592-008-0064-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLaczy, Boglárka | |
245 | 0 | 0 |
_aEffects of pentoxifylline and pentosan polysulphate combination therapy on diabetic neuropathy in type 2 diabetes mellitus. _h[electronic resource] |
260 |
_bActa diabetologica _cJun 2009 |
||
300 |
_a105-11 p. _bdigital |
||
500 | _aPublication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAlbuminuria _xphysiopathology |
650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
650 | 0 | 4 |
_aAutonomic Nervous System _xdrug effects |
650 | 0 | 4 | _aBlood Pressure |
650 | 0 | 4 | _aBody Mass Index |
650 | 0 | 4 |
_aCreatinine _xblood |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
650 | 0 | 4 |
_aDiabetic Neuropathies _xdrug therapy |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGlomerular Filtration Rate |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPentosan Sulfuric Polyester _xtherapeutic use |
650 | 0 | 4 |
_aPentoxifylline _xtherapeutic use |
650 | 0 | 4 | _aPlacebos |
650 | 0 | 4 | _aSensory Thresholds |
650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
650 | 0 | 4 | _aVibration |
700 | 1 | _aCseh, Judit | |
700 | 1 | _aMohás, Márton | |
700 | 1 | _aMarkó, Lajos | |
700 | 1 | _aTamaskó, Mónika | |
700 | 1 | _aKoszegi, Tamás | |
700 | 1 | _aMolnár, Gergo A | |
700 | 1 | _aWagner, Zoltán | |
700 | 1 | _aWagner, László | |
700 | 1 | _aWittmann, István | |
773 | 0 |
_tActa diabetologica _gvol. 46 _gno. 2 _gp. 105-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00592-008-0064-5 _zAvailable from publisher's website |
999 |
_c18304994 _d18304994 |